Cellectar Biosciences Company Insiders

Cellectar Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (1.66) % which means that it has lost $1.66 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.9667) %, meaning that it created substantial loss on money invested by shareholders. Cellectar Biosciences' management efficiency ratios could be used to measure how well Cellectar Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cellectar Biosciences' Return On Capital Employed is projected to increase significantly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 29.41, whereas Return On Tangible Assets are projected to grow to (2.99). At present, Cellectar Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 2 M, whereas Non Currrent Assets Other are forecasted to decline to about 28.3 K. The current year's Common Stock Shares Outstanding is expected to grow to about 12.8 M, whereas Net Loss is projected to grow to (24.5 M).

Cellectar Biosciences Workforce Comparison

Cellectar Biosciences Insider Trading

Cellectar Biosciences Notable Stakeholders

The success or failure of an entity such as Cellectar Biosciences often depends on how effective the management is. Cellectar Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cellectar management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cellectar management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Cellectar Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cellectar Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cellectar Biosciences' management manipulating its earnings.

When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.